» Articles » PMID: 38994950

Brain RFamide Neuropeptides in Stress-Related Psychopathologies

Abstract

The RFamide peptide family is a group of proteins that share a common C-terminal arginine-phenylalanine-amide motif. To date, the family comprises five groups in mammals: neuropeptide FF, LPXRFamides/RFamide-related peptides, prolactin releasing peptide, QRFP, and kisspeptins. Different RFamide peptides have their own cognate receptors and are produced by different cell populations, although they all can also bind to neuropeptide FF receptors with different affinities. RFamide peptides function in the brain as neuropeptides regulating key aspects of homeostasis such as energy balance, reproduction, and cardiovascular function. Furthermore, they are involved in the organization of the stress response including modulation of pain. Considering the interaction between stress and various parameters of homeostasis, the role of RFamide peptides may be critical in the development of stress-related neuropathologies. This review will therefore focus on the role of RFamide peptides as possible key hubs in stress and stress-related psychopathologies. The neurotransmitter coexpression profile of RFamide-producing cells is also discussed, highlighting its potential functional significance. The development of novel pharmaceutical agents for the treatment of stress-related disorders is an ongoing need. Thus, the importance of RFamide research is underlined by the emergence of peptidergic and G-protein coupled receptor-based therapeutic targets in the pharmaceutical industry.

Citing Articles

The Aggravating Role of Failing Neuropeptide Networks in the Development of Sporadic Alzheimer's Disease.

Jaszberenyi M, Thurzo B, Jayakumar A, Schally A Int J Mol Sci. 2024; 25(23).

PMID: 39684795 PMC: 11641508. DOI: 10.3390/ijms252313086.

References
1.
Kotlinska J, Gibula-Bruzda E, Koltunowska D, Raoof H, Suder P, Silberring J . Modulation of neuropeptide FF (NPFF) receptors influences the expression of amphetamine-induced conditioned place preference and amphetamine withdrawal anxiety-like behavior in rats. Peptides. 2011; 33(1):156-63. DOI: 10.1016/j.peptides.2011.12.002. View

2.
Govindarajan A, Rao B, Nair D, Trinh M, Mawjee N, Tonegawa S . Transgenic brain-derived neurotrophic factor expression causes both anxiogenic and antidepressant effects. Proc Natl Acad Sci U S A. 2006; 103(35):13208-13. PMC: 1559778. DOI: 10.1073/pnas.0605180103. View

3.
Bonini J, Jones K, Adham N, Forray C, Artymyshyn R, Durkin M . Identification and characterization of two G protein-coupled receptors for neuropeptide FF. J Biol Chem. 2000; 275(50):39324-31. DOI: 10.1074/jbc.M004385200. View

4.
Tanaka M, Csabafi K, Telegdy G . Neurotransmissions of antidepressant-like effects of kisspeptin-13. Regul Pept. 2012; 180:1-4. DOI: 10.1016/j.regpep.2012.08.017. View

5.
Prazienkova V, Popelova A, Kunes J, Maletinska L . Prolactin-Releasing Peptide: Physiological and Pharmacological Properties. Int J Mol Sci. 2019; 20(21). PMC: 6862262. DOI: 10.3390/ijms20215297. View